NCT06956755View on ClinicalTrials.gov

Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia

RecruitingOBSERVATIONAL
Enrollment

6,990

Participants

Timeline

Start Date

July 7, 2003

Primary Completion Date

January 5, 2030

Study Completion Date

January 5, 2031

Conditions
Myelodysplastic SyndromesLeukemia, Myeloid, Acute
Trial Locations (1)

76038

RECRUITING

Aspasia Stamatoullas, Rouen

All Listed Sponsors
lead

Groupe Francophone des Myelodysplasies

OTHER

NCT06956755 - Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter